Small and mid-sized biotech companies could see M&A action in the second half
designer491 As many large pharmaceutical companies continue to grapple with looming patent cliffs that will impact sales of key drugs, ...
designer491 As many large pharmaceutical companies continue to grapple with looming patent cliffs that will impact sales of key drugs, ...